Source-grounded facts extracted from Acadia Healthcare Company, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Acadia Healthcare Company, Inc. reported the first quarter ended March 31, 2026 results: revenue $828.8 million, net income $0.05 per diluted share, EPS $0.05 per diluted share. Guidance raised.
“Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Results ● Revenue totaled $828.8 million, a 7.6% increase compared with the first quarter of 2025 ● Same-facility revenue increased 7.3% compared with the first quarter of 2025, including an increase in revenue per”
Nasser Khan was appointed as Chief Operating Officer at Acadia Healthcare Company, Inc..
“Appointment of Dr. Nasser Khan as Chief Operating Officer On May 23, 2024, Acadia Healthcare Company, Inc. (the “Company”) announced the appointment of Dr. Nasser Khan as the Chief Operating Officer of the Company, effective June 30, 2024.”
Earnings Releases
Acadia Healthcare Company, Inc. reported first quarter ended March 31, 2024 results: revenue $768.1 million, net income $76.4 million, EPS $0.83 per diluted share. Guidance reaffirmed.
“2024 ) – Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2024. First Quarter Highlights ● Revenue totaled $768.1 million, an increase of 9.1% over the first quarter of 2023 ● Same facility revenue increased 9.2% compared with the first quarter of 2023, including an increase in revenue per patient”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.